nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A43—prostate cancer	0.314	0.736	CbGaD
Zalcitabine—CYP3A5—prostate cancer	0.0787	0.184	CbGaD
Zalcitabine—CYP3A4—prostate cancer	0.034	0.0798	CbGaD
Zalcitabine—CYP3A5—Flutamide—prostate cancer	0.0212	0.0655	CbGbCtD
Zalcitabine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.019	0.0587	CbGbCtD
Zalcitabine—SLC22A7—Docetaxel—prostate cancer	0.0181	0.0558	CbGbCtD
Zalcitabine—CYP2C9—Nilutamide—prostate cancer	0.0172	0.053	CbGbCtD
Zalcitabine—CYP2C9—Bicalutamide—prostate cancer	0.0172	0.053	CbGbCtD
Zalcitabine—CYP2D6—Bicalutamide—prostate cancer	0.0157	0.0485	CbGbCtD
Zalcitabine—CYP3A5—Cabazitaxel—prostate cancer	0.0157	0.0485	CbGbCtD
Zalcitabine—CYP3A5—Estrone—prostate cancer	0.0153	0.0474	CbGbCtD
Zalcitabine—SLC22A6—Conjugated Estrogens—prostate cancer	0.0146	0.0453	CbGbCtD
Zalcitabine—CYP2D6—Abiraterone—prostate cancer	0.013	0.0402	CbGbCtD
Zalcitabine—CYP3A7—Estradiol—prostate cancer	0.0117	0.0363	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0117	0.0363	CbGbCtD
Zalcitabine—CYP2C9—Estrone—prostate cancer	0.0103	0.0318	CbGbCtD
Zalcitabine—CYP3A4—Bicalutamide—prostate cancer	0.00998	0.0308	CbGbCtD
Zalcitabine—CYP3A4—Estramustine—prostate cancer	0.00927	0.0287	CbGbCtD
Zalcitabine—CYP3A5—Estradiol—prostate cancer	0.0088	0.0272	CbGbCtD
Zalcitabine—CYP3A4—Flutamide—prostate cancer	0.00827	0.0255	CbGbCtD
Zalcitabine—CYP3A4—Abiraterone—prostate cancer	0.00827	0.0255	CbGbCtD
Zalcitabine—CYP2C9—Capecitabine—prostate cancer	0.00779	0.0241	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00701	0.0217	CbGbCtD
Zalcitabine—CYP3A7—Docetaxel—prostate cancer	0.00701	0.0217	CbGbCtD
Zalcitabine—CYP3A4—Cabazitaxel—prostate cancer	0.00611	0.0189	CbGbCtD
Zalcitabine—CYP3A4—Estrone—prostate cancer	0.00598	0.0185	CbGbCtD
Zalcitabine—CYP2C9—Estradiol—prostate cancer	0.0059	0.0182	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—prostate cancer	0.00575	0.0178	CbGbCtD
Zalcitabine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00533	0.0165	CbGbCtD
Zalcitabine—CYP3A5—Docetaxel—prostate cancer	0.00526	0.0163	CbGbCtD
Zalcitabine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00391	0.0121	CbGbCtD
Zalcitabine—CYP3A4—Mitoxantrone—prostate cancer	0.00355	0.011	CbGbCtD
Zalcitabine—CYP3A4—Estradiol—prostate cancer	0.00343	0.0106	CbGbCtD
Zalcitabine—CYP3A4—Prednisone—prostate cancer	0.00295	0.00912	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—prostate cancer	0.0024	0.00743	CbGbCtD
Zalcitabine—CYP3A4—Etoposide—prostate cancer	0.00224	0.00693	CbGbCtD
Zalcitabine—CYP3A4—Docetaxel—prostate cancer	0.00205	0.00634	CbGbCtD
Zalcitabine—SLC29A2—prostate gland—prostate cancer	0.00197	0.114	CbGeAlD
Zalcitabine—CYP3A4—Doxorubicin—prostate cancer	0.00153	0.00472	CbGbCtD
Zalcitabine—CYP3A43—testis—prostate cancer	0.00135	0.0781	CbGeAlD
Zalcitabine—CYP2C9—urine—prostate cancer	0.00133	0.0769	CbGeAlD
Zalcitabine—CYP3A4—urine—prostate cancer	0.00101	0.0586	CbGeAlD
Zalcitabine—CYP2D6—urine—prostate cancer	0.000995	0.0577	CbGeAlD
Zalcitabine—SLC29A1—prostate gland—prostate cancer	0.000978	0.0567	CbGeAlD
Zalcitabine—DCK—prostate gland—prostate cancer	0.000934	0.0541	CbGeAlD
Zalcitabine—SLC22A7—renal system—prostate cancer	0.000864	0.0501	CbGeAlD
Zalcitabine—Decitabine—DNMT1—prostate cancer	0.000861	0.369	CrCbGaD
Zalcitabine—DCK—seminal vesicle—prostate cancer	0.00079	0.0458	CbGeAlD
Zalcitabine—SLC29A1—renal system—prostate cancer	0.000666	0.0386	CbGeAlD
Zalcitabine—SLC29A1—urethra—prostate cancer	0.000655	0.0379	CbGeAlD
Zalcitabine—SLC29A2—lymph node—prostate cancer	0.00063	0.0365	CbGeAlD
Zalcitabine—DCK—urethra—prostate cancer	0.000625	0.0362	CbGeAlD
Zalcitabine—SLC22A7—testis—prostate cancer	0.000558	0.0324	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—prostate cancer	0.000504	0.0292	CbGeAlD
Zalcitabine—CYP3A5—prostate gland—prostate cancer	0.000484	0.028	CbGeAlD
Zalcitabine—DCK—bone marrow—prostate cancer	0.000481	0.0279	CbGeAlD
Zalcitabine—Lamivudine—SLC22A3—prostate cancer	0.000439	0.188	CrCbGaD
Zalcitabine—SLC29A1—testis—prostate cancer	0.000431	0.025	CbGeAlD
Zalcitabine—DCK—testis—prostate cancer	0.000412	0.0239	CbGeAlD
Zalcitabine—Gemcitabine—TYMS—prostate cancer	0.000397	0.17	CrCbGaD
Zalcitabine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.000378	0.172	CbGdCrCtD
Zalcitabine—CYP3A5—renal system—prostate cancer	0.00033	0.0191	CbGeAlD
Zalcitabine—Lamivudine—SLC22A1—prostate cancer	0.000315	0.135	CrCbGaD
Zalcitabine—SLC29A1—lymph node—prostate cancer	0.000312	0.0181	CbGeAlD
Zalcitabine—DCK—Fulvestrant—Estradiol—prostate cancer	0.000306	0.139	CbGdCrCtD
Zalcitabine—DCK—lymph node—prostate cancer	0.000298	0.0173	CbGeAlD
Zalcitabine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.000287	0.13	CbGdCrCtD
Zalcitabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.00028	0.127	CbGdCrCtD
Zalcitabine—DCK—Levorphanol—Estrone—prostate cancer	0.000267	0.121	CbGdCrCtD
Zalcitabine—CYP3A4—renal system—prostate cancer	0.000247	0.0143	CbGeAlD
Zalcitabine—CYP2D6—renal system—prostate cancer	0.000243	0.0141	CbGeAlD
Zalcitabine—Cytarabine—SLC22A1—prostate cancer	0.000236	0.101	CrCbGaD
Zalcitabine—DCK—Levorphanol—Estradiol—prostate cancer	0.000202	0.0919	CbGdCrCtD
Zalcitabine—CYP2D6—testis—prostate cancer	0.000157	0.00912	CbGeAlD
Zalcitabine—DCK—Doxorubicin—Epirubicin—prostate cancer	0.00014	0.0639	CbGdCrCtD
Zalcitabine—DCK—Epirubicin—Doxorubicin—prostate cancer	0.00013	0.0591	CbGdCrCtD
Zalcitabine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	9.57e-05	0.0435	CbGdCrCtD
Zalcitabine—Cytarabine—CYP3A4—prostate cancer	8.25e-05	0.0354	CrCbGaD
Zalcitabine—DCK—Desoximetasone—Prednisone—prostate cancer	5.75e-05	0.0262	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisone—prostate cancer	5.58e-05	0.0254	CbGdCrCtD
Zalcitabine—Vomiting—Estradiol—prostate cancer	2.35e-05	0.000154	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Etoposide—prostate cancer	2.34e-05	0.000153	CcSEcCtD
Zalcitabine—Shock—Docetaxel—prostate cancer	2.34e-05	0.000153	CcSEcCtD
Zalcitabine—Ill-defined disorder—Prednisone—prostate cancer	2.33e-05	0.000153	CcSEcCtD
Zalcitabine—Thrombocytopenia—Docetaxel—prostate cancer	2.33e-05	0.000153	CcSEcCtD
Zalcitabine—Rash—Estradiol—prostate cancer	2.33e-05	0.000153	CcSEcCtD
Zalcitabine—Dermatitis—Estradiol—prostate cancer	2.33e-05	0.000152	CcSEcCtD
Zalcitabine—Anaemia—Prednisone—prostate cancer	2.32e-05	0.000152	CcSEcCtD
Zalcitabine—Confusional state—Capecitabine—prostate cancer	2.32e-05	0.000152	CcSEcCtD
Zalcitabine—Tachycardia—Docetaxel—prostate cancer	2.32e-05	0.000152	CcSEcCtD
Zalcitabine—Headache—Estradiol—prostate cancer	2.31e-05	0.000152	CcSEcCtD
Zalcitabine—Skin disorder—Docetaxel—prostate cancer	2.31e-05	0.000151	CcSEcCtD
Zalcitabine—Agitation—Prednisone—prostate cancer	2.31e-05	0.000151	CcSEcCtD
Zalcitabine—Oedema—Capecitabine—prostate cancer	2.3e-05	0.000151	CcSEcCtD
Zalcitabine—Infection—Capecitabine—prostate cancer	2.29e-05	0.00015	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—prostate cancer	2.28e-05	0.00015	CcSEcCtD
Zalcitabine—Urticaria—Etoposide—prostate cancer	2.27e-05	0.000149	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—prostate cancer	2.27e-05	0.000149	CcSEcCtD
Zalcitabine—Anorexia—Docetaxel—prostate cancer	2.27e-05	0.000149	CcSEcCtD
Zalcitabine—Malaise—Prednisone—prostate cancer	2.27e-05	0.000149	CcSEcCtD
Zalcitabine—Shock—Capecitabine—prostate cancer	2.27e-05	0.000148	CcSEcCtD
Zalcitabine—Rhinitis—Epirubicin—prostate cancer	2.26e-05	0.000148	CcSEcCtD
Zalcitabine—Body temperature increased—Etoposide—prostate cancer	2.26e-05	0.000148	CcSEcCtD
Zalcitabine—Abdominal pain—Etoposide—prostate cancer	2.26e-05	0.000148	CcSEcCtD
Zalcitabine—Vertigo—Prednisone—prostate cancer	2.26e-05	0.000148	CcSEcCtD
Zalcitabine—Hepatitis—Epirubicin—prostate cancer	2.26e-05	0.000148	CcSEcCtD
Zalcitabine—Thrombocytopenia—Capecitabine—prostate cancer	2.26e-05	0.000148	CcSEcCtD
Zalcitabine—Syncope—Prednisone—prostate cancer	2.25e-05	0.000148	CcSEcCtD
Zalcitabine—Tachycardia—Capecitabine—prostate cancer	2.25e-05	0.000147	CcSEcCtD
Zalcitabine—Pharyngitis—Epirubicin—prostate cancer	2.24e-05	0.000147	CcSEcCtD
Zalcitabine—Skin disorder—Capecitabine—prostate cancer	2.24e-05	0.000147	CcSEcCtD
Zalcitabine—Hyperhidrosis—Capecitabine—prostate cancer	2.23e-05	0.000146	CcSEcCtD
Zalcitabine—Loss of consciousness—Prednisone—prostate cancer	2.21e-05	0.000145	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—prostate cancer	2.2e-05	0.000144	CcSEcCtD
Zalcitabine—Anorexia—Capecitabine—prostate cancer	2.2e-05	0.000144	CcSEcCtD
Zalcitabine—Vomiting—Mitoxantrone—prostate cancer	2.19e-05	0.000143	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—prostate cancer	2.18e-05	0.000143	CcSEcCtD
Zalcitabine—Convulsion—Prednisone—prostate cancer	2.18e-05	0.000143	CcSEcCtD
Zalcitabine—Visual impairment—Epirubicin—prostate cancer	2.18e-05	0.000143	CcSEcCtD
Zalcitabine—Hypertension—Prednisone—prostate cancer	2.17e-05	0.000142	CcSEcCtD
Zalcitabine—Rash—Mitoxantrone—prostate cancer	2.17e-05	0.000142	CcSEcCtD
Zalcitabine—Dermatitis—Mitoxantrone—prostate cancer	2.17e-05	0.000142	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.17e-05	0.000142	CcSEcCtD
Zalcitabine—Headache—Mitoxantrone—prostate cancer	2.16e-05	0.000141	CcSEcCtD
Zalcitabine—Insomnia—Docetaxel—prostate cancer	2.15e-05	0.000141	CcSEcCtD
Zalcitabine—Arthralgia—Prednisone—prostate cancer	2.14e-05	0.00014	CcSEcCtD
Zalcitabine—Myalgia—Prednisone—prostate cancer	2.14e-05	0.00014	CcSEcCtD
Zalcitabine—Anxiety—Prednisone—prostate cancer	2.13e-05	0.00014	CcSEcCtD
Zalcitabine—Dyspnoea—Docetaxel—prostate cancer	2.12e-05	0.000139	CcSEcCtD
Zalcitabine—Somnolence—Docetaxel—prostate cancer	2.11e-05	0.000139	CcSEcCtD
Zalcitabine—Discomfort—Prednisone—prostate cancer	2.11e-05	0.000139	CcSEcCtD
Zalcitabine—Eye disorder—Epirubicin—prostate cancer	2.11e-05	0.000138	CcSEcCtD
Zalcitabine—Hypersensitivity—Etoposide—prostate cancer	2.11e-05	0.000138	CcSEcCtD
Zalcitabine—Tinnitus—Epirubicin—prostate cancer	2.11e-05	0.000138	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.1e-05	0.000138	CcSEcCtD
Zalcitabine—Flushing—Epirubicin—prostate cancer	2.1e-05	0.000137	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—prostate cancer	2.1e-05	0.000137	CcSEcCtD
Zalcitabine—Dyspepsia—Docetaxel—prostate cancer	2.09e-05	0.000137	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—prostate cancer	2.09e-05	0.000137	CcSEcCtD
Zalcitabine—Insomnia—Capecitabine—prostate cancer	2.08e-05	0.000137	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—prostate cancer	2.07e-05	0.000136	CcSEcCtD
Zalcitabine—Decreased appetite—Docetaxel—prostate cancer	2.07e-05	0.000136	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—prostate cancer	2.05e-05	0.000135	CcSEcCtD
Zalcitabine—Dyspnoea—Capecitabine—prostate cancer	2.05e-05	0.000135	CcSEcCtD
Zalcitabine—Oedema—Prednisone—prostate cancer	2.05e-05	0.000134	CcSEcCtD
Zalcitabine—Fatigue—Docetaxel—prostate cancer	2.05e-05	0.000134	CcSEcCtD
Zalcitabine—Infection—Prednisone—prostate cancer	2.04e-05	0.000134	CcSEcCtD
Zalcitabine—Pain—Docetaxel—prostate cancer	2.03e-05	0.000133	CcSEcCtD
Zalcitabine—Dyspepsia—Capecitabine—prostate cancer	2.03e-05	0.000133	CcSEcCtD
Zalcitabine—Chills—Epirubicin—prostate cancer	2.03e-05	0.000133	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—prostate cancer	2.03e-05	0.000133	CcSEcCtD
Zalcitabine—Shock—Prednisone—prostate cancer	2.02e-05	0.000132	CcSEcCtD
Zalcitabine—Arrhythmia—Epirubicin—prostate cancer	2.02e-05	0.000132	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—prostate cancer	2.01e-05	0.000132	CcSEcCtD
Zalcitabine—Tachycardia—Prednisone—prostate cancer	2e-05	0.000131	CcSEcCtD
Zalcitabine—Decreased appetite—Capecitabine—prostate cancer	2e-05	0.000131	CcSEcCtD
Zalcitabine—Alopecia—Epirubicin—prostate cancer	2e-05	0.000131	CcSEcCtD
Zalcitabine—Skin disorder—Prednisone—prostate cancer	1.99e-05	0.000131	CcSEcCtD
Zalcitabine—Fatigue—Capecitabine—prostate cancer	1.99e-05	0.00013	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisone—prostate cancer	1.98e-05	0.00013	CcSEcCtD
Zalcitabine—Pain—Capecitabine—prostate cancer	1.97e-05	0.000129	CcSEcCtD
Zalcitabine—Feeling abnormal—Docetaxel—prostate cancer	1.96e-05	0.000128	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—prostate cancer	1.96e-05	0.000128	CcSEcCtD
Zalcitabine—Anorexia—Prednisone—prostate cancer	1.96e-05	0.000128	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—prostate cancer	1.95e-05	0.000128	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—prostate cancer	1.95e-05	0.000128	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Docetaxel—prostate cancer	1.95e-05	0.000127	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—prostate cancer	1.94e-05	0.000127	CcSEcCtD
Zalcitabine—Flatulence—Epirubicin—prostate cancer	1.94e-05	0.000127	CcSEcCtD
Zalcitabine—Tension—Epirubicin—prostate cancer	1.93e-05	0.000126	CcSEcCtD
Zalcitabine—Dysgeusia—Epirubicin—prostate cancer	1.93e-05	0.000126	CcSEcCtD
Zalcitabine—Nervousness—Epirubicin—prostate cancer	1.91e-05	0.000125	CcSEcCtD
Zalcitabine—Back pain—Epirubicin—prostate cancer	1.9e-05	0.000125	CcSEcCtD
Zalcitabine—Feeling abnormal—Capecitabine—prostate cancer	1.9e-05	0.000124	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—prostate cancer	1.89e-05	0.000124	CcSEcCtD
Zalcitabine—Muscle spasms—Epirubicin—prostate cancer	1.89e-05	0.000124	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Capecitabine—prostate cancer	1.88e-05	0.000123	CcSEcCtD
Zalcitabine—Body temperature increased—Docetaxel—prostate cancer	1.88e-05	0.000123	CcSEcCtD
Zalcitabine—Abdominal pain—Docetaxel—prostate cancer	1.88e-05	0.000123	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—prostate cancer	1.88e-05	0.000123	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.87e-05	0.000122	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—prostate cancer	1.87e-05	0.000122	CcSEcCtD
Zalcitabine—Insomnia—Prednisone—prostate cancer	1.86e-05	0.000122	CcSEcCtD
Zalcitabine—Vision blurred—Epirubicin—prostate cancer	1.85e-05	0.000121	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—prostate cancer	1.85e-05	0.000121	CcSEcCtD
Zalcitabine—Urticaria—Capecitabine—prostate cancer	1.83e-05	0.00012	CcSEcCtD
Zalcitabine—Ill-defined disorder—Epirubicin—prostate cancer	1.82e-05	0.00012	CcSEcCtD
Zalcitabine—Abdominal pain—Capecitabine—prostate cancer	1.82e-05	0.000119	CcSEcCtD
Zalcitabine—Body temperature increased—Capecitabine—prostate cancer	1.82e-05	0.000119	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—prostate cancer	1.82e-05	0.000119	CcSEcCtD
Zalcitabine—Anaemia—Epirubicin—prostate cancer	1.82e-05	0.000119	CcSEcCtD
Zalcitabine—Agitation—Epirubicin—prostate cancer	1.81e-05	0.000118	CcSEcCtD
Zalcitabine—Dyspepsia—Prednisone—prostate cancer	1.81e-05	0.000118	CcSEcCtD
Zalcitabine—Rash—Etoposide—prostate cancer	1.8e-05	0.000118	CcSEcCtD
Zalcitabine—Dermatitis—Etoposide—prostate cancer	1.8e-05	0.000118	CcSEcCtD
Zalcitabine—Headache—Etoposide—prostate cancer	1.79e-05	0.000118	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—prostate cancer	1.79e-05	0.000117	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—prostate cancer	1.79e-05	0.000117	CcSEcCtD
Zalcitabine—Decreased appetite—Prednisone—prostate cancer	1.78e-05	0.000117	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—prostate cancer	1.78e-05	0.000117	CcSEcCtD
Zalcitabine—Malaise—Epirubicin—prostate cancer	1.77e-05	0.000116	CcSEcCtD
Zalcitabine—Fatigue—Prednisone—prostate cancer	1.77e-05	0.000116	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—prostate cancer	1.77e-05	0.000116	CcSEcCtD
Zalcitabine—Vertigo—Epirubicin—prostate cancer	1.77e-05	0.000116	CcSEcCtD
Zalcitabine—Syncope—Epirubicin—prostate cancer	1.76e-05	0.000116	CcSEcCtD
Zalcitabine—Leukopenia—Epirubicin—prostate cancer	1.76e-05	0.000115	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—prostate cancer	1.76e-05	0.000115	CcSEcCtD
Zalcitabine—Hypersensitivity—Docetaxel—prostate cancer	1.75e-05	0.000115	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—prostate cancer	1.75e-05	0.000115	CcSEcCtD
Zalcitabine—Palpitations—Epirubicin—prostate cancer	1.74e-05	0.000114	CcSEcCtD
Zalcitabine—Loss of consciousness—Epirubicin—prostate cancer	1.73e-05	0.000113	CcSEcCtD
Zalcitabine—Cough—Epirubicin—prostate cancer	1.72e-05	0.000112	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—prostate cancer	1.71e-05	0.000112	CcSEcCtD
Zalcitabine—Asthenia—Docetaxel—prostate cancer	1.71e-05	0.000112	CcSEcCtD
Zalcitabine—Convulsion—Epirubicin—prostate cancer	1.7e-05	0.000112	CcSEcCtD
Zalcitabine—Hypertension—Epirubicin—prostate cancer	1.7e-05	0.000111	CcSEcCtD
Zalcitabine—Hypersensitivity—Capecitabine—prostate cancer	1.7e-05	0.000111	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisone—prostate cancer	1.69e-05	0.000111	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—prostate cancer	1.69e-05	0.000111	CcSEcCtD
Zalcitabine—Pruritus—Docetaxel—prostate cancer	1.68e-05	0.00011	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—prostate cancer	1.68e-05	0.00011	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Prednisone—prostate cancer	1.68e-05	0.00011	CcSEcCtD
Zalcitabine—Myalgia—Epirubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Zalcitabine—Arthralgia—Epirubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Zalcitabine—Anxiety—Epirubicin—prostate cancer	1.67e-05	0.000109	CcSEcCtD
Zalcitabine—Discomfort—Epirubicin—prostate cancer	1.65e-05	0.000108	CcSEcCtD
Zalcitabine—Asthenia—Capecitabine—prostate cancer	1.65e-05	0.000108	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—prostate cancer	1.64e-05	0.000108	CcSEcCtD
Zalcitabine—Dry mouth—Epirubicin—prostate cancer	1.64e-05	0.000107	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Zalcitabine—Urticaria—Prednisone—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Zalcitabine—Pruritus—Capecitabine—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Zalcitabine—Diarrhoea—Docetaxel—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Zalcitabine—Abdominal pain—Prednisone—prostate cancer	1.62e-05	0.000106	CcSEcCtD
Zalcitabine—Body temperature increased—Prednisone—prostate cancer	1.62e-05	0.000106	CcSEcCtD
Zalcitabine—Confusional state—Epirubicin—prostate cancer	1.62e-05	0.000106	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—prostate cancer	1.61e-05	0.000105	CcSEcCtD
Zalcitabine—Oedema—Epirubicin—prostate cancer	1.6e-05	0.000105	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—prostate cancer	1.6e-05	0.000105	CcSEcCtD
Zalcitabine—Infection—Epirubicin—prostate cancer	1.59e-05	0.000104	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—prostate cancer	1.59e-05	0.000104	CcSEcCtD
Zalcitabine—Shock—Epirubicin—prostate cancer	1.58e-05	0.000103	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—prostate cancer	1.58e-05	0.000103	CcSEcCtD
Zalcitabine—Diarrhoea—Capecitabine—prostate cancer	1.58e-05	0.000103	CcSEcCtD
Zalcitabine—Dizziness—Docetaxel—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Zalcitabine—Thrombocytopenia—Epirubicin—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Zalcitabine—Tachycardia—Epirubicin—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Zalcitabine—Skin disorder—Epirubicin—prostate cancer	1.56e-05	0.000102	CcSEcCtD
Zalcitabine—Hyperhidrosis—Epirubicin—prostate cancer	1.55e-05	0.000102	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—prostate cancer	1.55e-05	0.000101	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—prostate cancer	1.55e-05	0.000101	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—prostate cancer	1.54e-05	0.000101	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—prostate cancer	1.53e-05	0.0001	CcSEcCtD
Zalcitabine—Anorexia—Epirubicin—prostate cancer	1.53e-05	0.0001	CcSEcCtD
Zalcitabine—Dizziness—Capecitabine—prostate cancer	1.52e-05	9.98e-05	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—prostate cancer	1.51e-05	9.93e-05	CcSEcCtD
Zalcitabine—Vomiting—Docetaxel—prostate cancer	1.51e-05	9.91e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisone—prostate cancer	1.51e-05	9.91e-05	CcSEcCtD
Zalcitabine—Rash—Docetaxel—prostate cancer	1.5e-05	9.83e-05	CcSEcCtD
Zalcitabine—Dermatitis—Docetaxel—prostate cancer	1.5e-05	9.82e-05	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—prostate cancer	1.5e-05	9.81e-05	CcSEcCtD
Zalcitabine—Headache—Docetaxel—prostate cancer	1.49e-05	9.77e-05	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—prostate cancer	1.48e-05	9.73e-05	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—prostate cancer	1.47e-05	9.67e-05	CcSEcCtD
Zalcitabine—Asthenia—Prednisone—prostate cancer	1.47e-05	9.65e-05	CcSEcCtD
Zalcitabine—Vomiting—Capecitabine—prostate cancer	1.46e-05	9.6e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.46e-05	9.58e-05	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—prostate cancer	1.46e-05	9.57e-05	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—prostate cancer	1.45e-05	9.53e-05	CcSEcCtD
Zalcitabine—Rash—Capecitabine—prostate cancer	1.45e-05	9.52e-05	CcSEcCtD
Zalcitabine—Pruritus—Prednisone—prostate cancer	1.45e-05	9.51e-05	CcSEcCtD
Zalcitabine—Insomnia—Epirubicin—prostate cancer	1.45e-05	9.51e-05	CcSEcCtD
Zalcitabine—Dermatitis—Capecitabine—prostate cancer	1.45e-05	9.51e-05	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—prostate cancer	1.45e-05	9.5e-05	CcSEcCtD
Zalcitabine—Headache—Capecitabine—prostate cancer	1.44e-05	9.46e-05	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—prostate cancer	1.44e-05	9.45e-05	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—prostate cancer	1.44e-05	9.41e-05	CcSEcCtD
Zalcitabine—Dyspnoea—Epirubicin—prostate cancer	1.43e-05	9.37e-05	CcSEcCtD
Zalcitabine—Somnolence—Epirubicin—prostate cancer	1.43e-05	9.35e-05	CcSEcCtD
Zalcitabine—Anorexia—Doxorubicin—prostate cancer	1.42e-05	9.27e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Epirubicin—prostate cancer	1.41e-05	9.26e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Prednisone—prostate cancer	1.4e-05	9.2e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Epirubicin—prostate cancer	1.39e-05	9.14e-05	CcSEcCtD
Zalcitabine—Fatigue—Epirubicin—prostate cancer	1.38e-05	9.07e-05	CcSEcCtD
Zalcitabine—Pain—Epirubicin—prostate cancer	1.37e-05	8.99e-05	CcSEcCtD
Zalcitabine—Dizziness—Prednisone—prostate cancer	1.36e-05	8.89e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.35e-05	8.86e-05	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—prostate cancer	1.34e-05	8.8e-05	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—prostate cancer	1.32e-05	8.67e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Epirubicin—prostate cancer	1.32e-05	8.66e-05	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—prostate cancer	1.32e-05	8.65e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Epirubicin—prostate cancer	1.31e-05	8.6e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—prostate cancer	1.31e-05	8.56e-05	CcSEcCtD
Zalcitabine—Vomiting—Prednisone—prostate cancer	1.3e-05	8.55e-05	CcSEcCtD
Zalcitabine—Rash—Prednisone—prostate cancer	1.29e-05	8.48e-05	CcSEcCtD
Zalcitabine—Dermatitis—Prednisone—prostate cancer	1.29e-05	8.47e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—prostate cancer	1.29e-05	8.46e-05	CcSEcCtD
Zalcitabine—Headache—Prednisone—prostate cancer	1.29e-05	8.42e-05	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—prostate cancer	1.28e-05	8.39e-05	CcSEcCtD
Zalcitabine—Urticaria—Epirubicin—prostate cancer	1.27e-05	8.35e-05	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—prostate cancer	1.27e-05	8.32e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Epirubicin—prostate cancer	1.27e-05	8.31e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Epirubicin—prostate cancer	1.27e-05	8.31e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—prostate cancer	1.22e-05	8.02e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.21e-05	7.96e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Epirubicin—prostate cancer	1.18e-05	7.75e-05	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—prostate cancer	1.18e-05	7.73e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—prostate cancer	1.17e-05	7.69e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—prostate cancer	1.17e-05	7.69e-05	CcSEcCtD
Zalcitabine—Asthenia—Epirubicin—prostate cancer	1.15e-05	7.54e-05	CcSEcCtD
Zalcitabine—Pruritus—Epirubicin—prostate cancer	1.14e-05	7.44e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Epirubicin—prostate cancer	1.1e-05	7.19e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—prostate cancer	1.09e-05	7.17e-05	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—prostate cancer	1.07e-05	6.98e-05	CcSEcCtD
Zalcitabine—Dizziness—Epirubicin—prostate cancer	1.06e-05	6.95e-05	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—prostate cancer	1.05e-05	6.88e-05	CcSEcCtD
Zalcitabine—Vomiting—Epirubicin—prostate cancer	1.02e-05	6.69e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—prostate cancer	1.02e-05	6.66e-05	CcSEcCtD
Zalcitabine—Rash—Epirubicin—prostate cancer	1.01e-05	6.63e-05	CcSEcCtD
Zalcitabine—Dermatitis—Epirubicin—prostate cancer	1.01e-05	6.62e-05	CcSEcCtD
Zalcitabine—Headache—Epirubicin—prostate cancer	1.01e-05	6.59e-05	CcSEcCtD
Zalcitabine—Dizziness—Doxorubicin—prostate cancer	9.82e-06	6.43e-05	CcSEcCtD
Zalcitabine—Vomiting—Doxorubicin—prostate cancer	9.44e-06	6.19e-05	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—prostate cancer	9.36e-06	6.13e-05	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—prostate cancer	9.35e-06	6.13e-05	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—prostate cancer	9.3e-06	6.09e-05	CcSEcCtD
Zalcitabine—CYP2D6—Metabolism—GSTA1—prostate cancer	3.69e-06	4.89e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA1—prostate cancer	3.66e-06	4.85e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTO1—prostate cancer	3.65e-06	4.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HSD3B2—prostate cancer	3.65e-06	4.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NAT2—prostate cancer	3.65e-06	4.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HSD3B2—prostate cancer	3.62e-06	4.8e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTO1—prostate cancer	3.62e-06	4.8e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NAT2—prostate cancer	3.62e-06	4.8e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOA2—prostate cancer	3.59e-06	4.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TYMS—prostate cancer	3.55e-06	4.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—prostate cancer	3.51e-06	4.65e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLCB2—prostate cancer	3.5e-06	4.64e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2C18—prostate cancer	3.5e-06	4.64e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LRP2—prostate cancer	3.5e-06	4.64e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.48e-06	4.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.48e-06	4.61e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLCB2—prostate cancer	3.47e-06	4.6e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LRP2—prostate cancer	3.47e-06	4.6e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2C18—prostate cancer	3.47e-06	4.6e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LPL—prostate cancer	3.45e-06	4.56e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—P4HB—prostate cancer	3.43e-06	4.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC5A5—prostate cancer	3.43e-06	4.54e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—P4HB—prostate cancer	3.4e-06	4.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.39e-06	4.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTAP—prostate cancer	3.39e-06	4.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2E1—prostate cancer	3.35e-06	4.44e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC22A1—prostate cancer	3.34e-06	4.43e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A1—prostate cancer	3.33e-06	4.41e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC22A1—prostate cancer	3.31e-06	4.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NQO1—prostate cancer	3.31e-06	4.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.3e-06	4.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.3e-06	4.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ERCC2—prostate cancer	3.3e-06	4.37e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.27e-06	4.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TH—prostate cancer	3.26e-06	4.32e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SULT2A1—prostate cancer	3.26e-06	4.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP3A4—prostate cancer	3.23e-06	4.28e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SULT2A1—prostate cancer	3.23e-06	4.28e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MED12—prostate cancer	3.2e-06	4.24e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNG5—prostate cancer	3.18e-06	4.21e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MED12—prostate cancer	3.18e-06	4.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1B1—prostate cancer	3.17e-06	4.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.15e-06	4.17e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACSL4—prostate cancer	3.15e-06	4.17e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNG5—prostate cancer	3.15e-06	4.17e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—prostate cancer	3.1e-06	4.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GGT1—prostate cancer	3.07e-06	4.07e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—prostate cancer	3.07e-06	4.07e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOA3—prostate cancer	3.06e-06	4.06e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARA—prostate cancer	3.04e-06	4.03e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOA3—prostate cancer	3.03e-06	4.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOA1—prostate cancer	3.03e-06	4.01e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—prostate cancer	3.02e-06	4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ARG2—prostate cancer	3.02e-06	4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PHGDH—prostate cancer	3.02e-06	4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UMPS—prostate cancer	3.02e-06	4e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP19A1—prostate cancer	2.98e-06	3.95e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.98e-06	3.95e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LDHB—prostate cancer	2.96e-06	3.93e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HPGDS—prostate cancer	2.92e-06	3.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.91e-06	3.85e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.9e-06	3.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HPGDS—prostate cancer	2.9e-06	3.84e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—RXRA—prostate cancer	2.88e-06	3.82e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2C19—prostate cancer	2.88e-06	3.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAV1—prostate cancer	2.86e-06	3.79e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ACHE—prostate cancer	2.83e-06	3.75e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—prostate cancer	2.83e-06	3.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PDHA1—prostate cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA3—prostate cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UCP3—prostate cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TCN2—prostate cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—prostate cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ACHE—prostate cancer	2.81e-06	3.72e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.8e-06	3.71e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2A6—prostate cancer	2.78e-06	3.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—COMT—prostate cancer	2.77e-06	3.68e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—prostate cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.72e-06	3.61e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ITPR1—prostate cancer	2.72e-06	3.6e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PRKACB—prostate cancer	2.71e-06	3.59e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKR1C3—prostate cancer	2.7e-06	3.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PRKACB—prostate cancer	2.69e-06	3.56e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.68e-06	3.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.68e-06	3.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.68e-06	3.55e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP17A1—prostate cancer	2.66e-06	3.52e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.62e-06	3.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—prostate cancer	2.61e-06	3.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.57e-06	3.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA4—prostate cancer	2.57e-06	3.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TYMS—prostate cancer	2.57e-06	3.4e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOA2—prostate cancer	2.55e-06	3.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—prostate cancer	2.54e-06	3.36e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOA2—prostate cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—prostate cancer	2.51e-06	3.32e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.5e-06	3.32e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LPL—prostate cancer	2.49e-06	3.3e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.47e-06	3.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.47e-06	3.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—prostate cancer	2.47e-06	3.27e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—INS—prostate cancer	2.47e-06	3.27e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.44e-06	3.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CREBBP—prostate cancer	2.42e-06	3.2e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.42e-06	3.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.42e-06	3.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.41e-06	3.19e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.39e-06	3.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.39e-06	3.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NAT2—prostate cancer	2.39e-06	3.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ERCC2—prostate cancer	2.39e-06	3.16e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.38e-06	3.15e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.36e-06	3.13e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NQO1—prostate cancer	2.35e-06	3.12e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NQO1—prostate cancer	2.33e-06	3.09e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TH—prostate cancer	2.32e-06	3.07e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TH—prostate cancer	2.3e-06	3.05e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.3e-06	3.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.29e-06	3.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.29e-06	3.03e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LRP2—prostate cancer	2.29e-06	3.03e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.29e-06	3.03e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.29e-06	3.03e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.28e-06	3.01e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.26e-06	3e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.26e-06	2.99e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—P4HB—prostate cancer	2.25e-06	2.97e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—prostate cancer	2.24e-06	2.97e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.24e-06	2.96e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARA—prostate cancer	2.2e-06	2.91e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GGT1—prostate cancer	2.19e-06	2.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.18e-06	2.89e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GGT1—prostate cancer	2.17e-06	2.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NOS3—prostate cancer	2.16e-06	2.87e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.15e-06	2.85e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.13e-06	2.83e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.13e-06	2.82e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.12e-06	2.81e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.1e-06	2.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MED12—prostate cancer	2.09e-06	2.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNG5—prostate cancer	2.08e-06	2.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAV1—prostate cancer	2.07e-06	2.74e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—RXRA—prostate cancer	2.05e-06	2.71e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—RXRA—prostate cancer	2.03e-06	2.69e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOA3—prostate cancer	2e-06	2.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—prostate cancer	2e-06	2.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—prostate cancer	1.98e-06	2.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.97e-06	2.62e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—COMT—prostate cancer	1.97e-06	2.61e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—COMT—prostate cancer	1.96e-06	2.59e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—prostate cancer	1.95e-06	2.58e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.93e-06	2.56e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.92e-06	2.54e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.91e-06	2.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.9e-06	2.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.88e-06	2.5e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACHE—prostate cancer	1.85e-06	2.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.85e-06	2.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.83e-06	2.43e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TYMS—prostate cancer	1.83e-06	2.42e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TYMS—prostate cancer	1.81e-06	2.4e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.8e-06	2.39e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.79e-06	2.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—INS—prostate cancer	1.78e-06	2.36e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.78e-06	2.36e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LPL—prostate cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LPL—prostate cancer	1.76e-06	2.33e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.75e-06	2.32e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CREBBP—prostate cancer	1.75e-06	2.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—prostate cancer	1.73e-06	2.29e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.71e-06	2.27e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.7e-06	2.25e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.7e-06	2.25e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.68e-06	2.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.67e-06	2.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.66e-06	2.19e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—EP300—prostate cancer	1.65e-06	2.18e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.59e-06	2.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.59e-06	2.11e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.58e-06	2.09e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARA—prostate cancer	1.56e-06	2.07e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NOS3—prostate cancer	1.56e-06	2.07e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.56e-06	2.06e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARA—prostate cancer	1.55e-06	2.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NQO1—prostate cancer	1.54e-06	2.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TH—prostate cancer	1.52e-06	2.01e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.48e-06	1.95e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAV1—prostate cancer	1.47e-06	1.95e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAV1—prostate cancer	1.46e-06	1.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.44e-06	1.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—prostate cancer	1.43e-06	1.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GGT1—prostate cancer	1.43e-06	1.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.41e-06	1.86e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.39e-06	1.85e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.39e-06	1.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.34e-06	1.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—RXRA—prostate cancer	1.34e-06	1.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.33e-06	1.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—COMT—prostate cancer	1.29e-06	1.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.28e-06	1.7e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—INS—prostate cancer	1.27e-06	1.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.26e-06	1.67e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—INS—prostate cancer	1.26e-06	1.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—prostate cancer	1.25e-06	1.65e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.24e-06	1.65e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.23e-06	1.63e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.61e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TYMS—prostate cancer	1.19e-06	1.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—EP300—prostate cancer	1.19e-06	1.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.18e-06	1.56e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.18e-06	1.56e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.17e-06	1.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LPL—prostate cancer	1.16e-06	1.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.12e-06	1.48e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NOS3—prostate cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NOS3—prostate cancer	1.1e-06	1.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.04e-06	1.38e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.03e-06	1.36e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARA—prostate cancer	1.02e-06	1.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.02e-06	1.35e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.02e-06	1.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.01e-06	1.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—prostate cancer	9.95e-07	1.32e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAV1—prostate cancer	9.62e-07	1.27e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—prostate cancer	8.87e-07	1.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—prostate cancer	8.8e-07	1.17e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—prostate cancer	8.79e-07	1.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.76e-07	1.16e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—EP300—prostate cancer	8.46e-07	1.12e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—EP300—prostate cancer	8.39e-07	1.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—INS—prostate cancer	8.29e-07	1.1e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CREBBP—prostate cancer	8.12e-07	1.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.7e-07	1.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NOS3—prostate cancer	7.27e-07	9.63e-06	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—prostate cancer	7.19e-07	9.52e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.71e-07	8.89e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—prostate cancer	6.65e-07	8.81e-06	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.26e-07	8.29e-06	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.2e-07	8.22e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—prostate cancer	5.8e-07	7.68e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—EP300—prostate cancer	5.53e-07	7.33e-06	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—prostate cancer	5.11e-07	6.77e-06	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—prostate cancer	5.07e-07	6.71e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.09e-07	5.42e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—prostate cancer	3.34e-07	4.43e-06	CbGpPWpGaD
